Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trialSandra Heesch, Uğur Şahin, Heinrich Haas et al.|Cancer Research|2016Cited by 5
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancerKatrin Frenzel, Uğur Şahin, Ludwig Heesen et al.|Annals of Oncology|2017Cited by 2
Abstract CT201: The Mutanome Engineered RNA Immuno-Therapy (MERIT) projectSandra Heesch, Uğur Şahin, Cedrik M. Britten et al.|Cancer Research|2015Cited by 1